NDC 59762-1530-2 - amlodipine besylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-1530
- Requested NDC
- 59762-1530-2
- Package NDCs from labels
- 59762-1530-2
- Manufacturer
- RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited
- Effective date
- 2011-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| amlodipine besylate - RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited | RedPharm Drug Inc. | Pfizer Pharmaceuticals LLC | Hetero Drugs Limited | 2011-08-03 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-1530-1 | EA - Each | 59762-1530 | 33f98858-6344-41d0-b915-1de2df042cb5 | 1 | 2012-07-24 |
| 59762-1530-2 | EA - Each | 59762-1530 | 8a32a6b4-a5fc-43e1-9f0b-8fa4525cb7bb | 1 | 2012-07-24 |
| 59762-1530-3 | EA - Each | 59762-1530 | 870fd041-5725-4d60-b332-1b412ec77377 | 1 | 2012-07-24 |
| 59762-1530-4 | EA - Each | 59762-1530 | 86429126-4c69-4d32-9aff-f6377ab760b9 | 1 | 2012-07-24 |
| 59762-1530-5 | EA - Each | 59762-1530 | b14b19c2-d0b3-4d43-8c7f-14f964865447 | 1 | 2012-07-24 |
| 59762-1530-6 | EA - Each | 59762-1530 | d3aebcb9-4905-4e50-8e8f-34b2e99e96cd | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| amlodipine besylate | ACTIVE INGREDIENT | 864V2Q084H | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| amlodipine | ACTIVE MOIETY | 1J444QC288 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| anhydrous dibasic calcium phosphate | INACTIVE INGREDIENT | L11K75P92J | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 | |
| sodium starch glycolate type A potato | INACTIVE INGREDIENT | 5856J3G2A2 | AMLODIPINE BESYLATE TABLET [REDPHARM DRUG INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE and OLMESARTAN medoxomil | AMLODIPINE AND OLMESARTAN MEDOXOMIL | Macleods Pharmaceuticals Limited | c86a3c45-c906-46c9-9f7b-6c3d89bbe48f | 2026-01-03 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Northwind Health Company, LLC | fa153720-b24c-60d0-e053-6294a90a97d5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Benazepril Hydrochloride | AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE | Northwind Health Company, LLC | f2b56630-4e3a-6f9c-e053-2a95a90a4650 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | f2b8274b-d849-6793-e053-2a95a90aa0e8 | 2026-01-01 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | f32bb322-68d7-a4ca-e053-2995a90aa7b0 | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 0c5784b9-5542-144f-e063-6394a90a7ebc | 2026-01-01 | Warnings, Adverse reactions | 197361 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 03fe9ad2-3a1a-78db-e063-6294a90a2ed3 | 2026-01-01 | Warnings, Adverse reactions | 864V2Q084H |
| amlodipine and valsartan | AMLODIPINE AND VALSARTAN | Macleods Pharmaceuticals Limited | 5dfadaf0-c333-4b79-9a97-e42f77505c40 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 0de6a6d0-a114-e114-e063-6394a90a34dd | 2025-12-26 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | Northwind Health Company, LLC | 106c08c2-90eb-6bc0-e063-6294a90a5a23 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 2b0e3752-c54e-4c50-9640-1a6fefa6dec5 | 2025-12-19 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Epic Pharma, LLC | 090f3e51-8129-4b5d-97f9-ab410e14df2d | 2025-12-17 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 7a75935a-31af-4571-b7d9-8c297a635b57 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Ascend Laboratories, LLC | 2b0bcb95-dc85-46f7-8b69-ca55cd58b30e | 2025-12-10 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine Besylate | AMLODIPINE BESYLATE | QPharma Inc | 3f74ed2b-4712-4026-ac2c-9239a211dde3 | 2025-12-05 | Warnings, Adverse reactions | 197361 864V2Q084H |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Cipla USA Inc. | 5409b296-3bed-47cd-abba-9fe6f6833af6 | 2025-12-03 | Warnings, Adverse reactions | 197361 864V2Q084H |
| Amlodipine besylate and Olmesartan medoxomil | AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL | Ajanta Pharma USA Inc. | 69fa6293-b10a-4473-ab9b-1bd53f099bdd | 2025-11-30 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| OLMESARTAN MEDOXOMIL, AMLODIPINE and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Micro Labs Limited | 9fb71df8-f70f-47dc-9465-8d8748261caf | 2025-11-29 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine and Atorvastatin | AMLODIPINE AND ATORVASTATIN | Bryant Ranch Prepack | be709711-e7ee-403f-ad43-873761deee37 | 2025-10-30 | Warnings, Adverse reactions | 864V2Q084H |
| Amlodipine Besylate and Benazepril Hydrochloride | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | A-S Medication Solutions | 3ad66075-0875-4703-9d21-a424b5ab892a | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 864V2Q084H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.